2001 - 2050 of 7665 Results
Title
Year
- Association of vitamin K with cognitive decline and neuropathology in community‐dwelling older persons2022RESTRICTEDTitle: Association of vitamin K with cognitive decline and neuropathology in community‐dwelling older personsJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12255Best OA location URL: https://doi.org/10.1002/trc2.12255Citation Count: 20
- At a Glance: An Update on Neuroimaging and Retinal Imaging in Alzheimer’s Disease and Related Research2022RESTRICTEDTitle: At a Glance: An Update on Neuroimaging and Retinal Imaging in Alzheimer’s Disease and Related ResearchJournal Name: The Journal Of Prevention of Alzheimer's DiseasePublisher: SERDIVol:Issue #:Start Page: 1End Page: 10Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.14283/jpad.2022.7Best OA location URL: https://link.springer.com/content/pdf/10.14283/jpad.2022.7.pdfCitation Count: 0
-
RESTRICTEDTitle: Auto-annotating sleep stages based on polysomnographic dataJournal Name: PatternsPublisher: Elsevier BVVol: 3Issue #: 1Start Page: 100371End Page: 100371Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.patter.2021.100371Best OA location URL: http://www.cell.com/article/S2666389921002336/pdfCitation Count: 14
- c‐Abl Inhibitors as Disease‐Modifying Therapies for Parkinson's Disease: Gaps and Opportunities2022RESTRICTEDTitle: c‐Abl Inhibitors as Disease‐Modifying Therapies for Parkinson's Disease: Gaps and OpportunitiesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 3End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28907Citation Count: 3
- Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET study2022RESTRICTEDTitle: Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET studyJournal Name: Aging BrainPublisher: Elsevier BVVol: 2Issue #:Start Page: 100039End Page: 100039Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbas.2022.100039Best OA location URL: https://doi.org/10.1016/j.nbas.2022.100039Citation Count: 16
- Change in the Parkinson Anxiety Scale correlates with change in other clinical measures of anxiety over time2022RESTRICTEDTitle: Change in the Parkinson Anxiety Scale correlates with change in other clinical measures of anxiety over timeJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 6Issue #:Start Page: 100126End Page: 100126Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100126Best OA location URL: https://doi.org/10.1016/j.prdoa.2021.100126Citation Count: 1
- Chemoproteomic-enabled characterization of small GTPase Rab1a as a target of an N-arylbenzimidazole ligand's rescue of Parkinson's-associated cell toxicity2022RESTRICTEDTitle: Chemoproteomic-enabled characterization of small GTPase Rab1a as a target of an N-arylbenzimidazole ligand's rescue of Parkinson's-associated cell toxicityJournal Name: RSC Chemical BiologyPublisher: Royal Society of Chemistry (RSC)Vol: 3Issue #: 1Start Page: 96End Page: 111Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/d1cb00103eBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2022/cb/d1cb00103eCitation Count: 5
-
RESTRICTEDTitle: Clinical neurophysiology of Parkinson’s disease and parkinsonismJournal Name: Clinical Neurophysiology PracticePublisher: Elsevier BVVol: 7Issue #:Start Page: 201End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cnp.2022.06.002Best OA location URL: https://doi.org/10.1016/j.cnp.2022.06.002Citation Count: 33
- Concurrent validity of Zeno instrumented walkway and video-based gait features in adults with Parkinson’s disease2022RESTRICTEDTitle: Concurrent validity of Zeno instrumented walkway and video-based gait features in adults with Parkinson’s diseaseJournal Name: IEEE Journal of Translational Engineering in Health and MedicinePublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 10Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1109/jtehm.2022.3180231Best OA location URL: https://ieeexplore.ieee.org/ielx7/6221039/6563131/09787410.pdfCitation Count: 9
- Co-registration of Imaging Modalities (MRI, CT and PET) to Perform Frameless Stereotaxic Robotic Injections in the Common Marmoset2022RESTRICTEDTitle: Co-registration of Imaging Modalities (MRI, CT and PET) to Perform Frameless Stereotaxic Robotic Injections in the Common MarmosetJournal Name: NeurosciencePublisher: Elsevier BVVol: 480Issue #:Start Page: 143End Page: 154Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2021.11.009Citation Count: 7
-
RESTRICTEDTitle: COVID-19 Vaccination Reactogenicity in Persons With Multiple SclerosisJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000001104Best OA location URL: https://nn.neurology.org/content/nnn/9/1/e1104.full.pdfCitation Count: 29
- Deep brain stimulation effect on anterior pallidum reduces motor impulsivity in Parkinson's disease2022RESTRICTEDTitle: Deep brain stimulation effect on anterior pallidum reduces motor impulsivity in Parkinson's diseaseJournal Name: Brain StimulationPublisher: Elsevier BVVol: 15Issue #: 1Start Page: 23End Page: 31Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.brs.2021.11.006Best OA location URL: http://www.brainstimjrnl.com/article/S1935861X21008044/pdfCitation Count: 3
- Deep learning for Parkinson’s disease symptom detection and severity evaluation using accelerometer signal2022OPENTitle: Deep learning for Parkinson’s disease symptom detection and severity evaluation using accelerometer signalJournal Name: ESANN 2022 proceedingsPublisher: Ciaco - i6doc.comVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.14428/esann/2022.es2022-107Best OA location URL: https://doi.org/10.14428/esann/2022.es2022-107Citation Count: 0
- Define and visualize pathological architectures of human tissues from spatially resolved transcriptomics using deep learning2022RESTRICTEDTitle: Define and visualize pathological architectures of human tissues from spatially resolved transcriptomics using deep learningJournal Name: Computational and Structural Biotechnology JournalPublisher: Elsevier BVVol: 20Issue #:Start Page: 4600End Page: 4617Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.csbj.2022.08.029Best OA location URL: https://doi.org/10.1016/j.csbj.2022.08.029Citation Count: 19
-
RESTRICTEDTitle: Depression and Parkinson's disease: a Chicken-Egg storyJournal Name: AIMS NeurosciencePublisher: American Institute of Mathematical Sciences (AIMS)Vol: 9Issue #: 4Start Page: 479End Page: 490Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3934/neuroscience.2022027Best OA location URL: https://doi.org/10.3934/neuroscience.2022027Citation Count: 2
-
RESTRICTEDTitle: Detection of emerging neurodegeneration using Bayesian linear mixed-effect modelingJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 36Issue #:Start Page: 103144End Page: 103144Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103144Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103144Citation Count: 1
-
RESTRICTEDTitle: Distinct atrophy of septal nuclei in Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 7Issue #:Start Page: 100171End Page: 100171Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100171Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100171Citation Count: 1
-
RESTRICTEDTitle: DNA Sequence Analysis for Brain Disorder Using Deep Learning and Secure StorageJournal Name: Computers, Materials & ContinuaPublisher: Computers, Materials and Continua (Tech Science Press)Vol: 71Issue #: 3Start Page: 5949End Page: 5962Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.32604/cmc.2022.022028Best OA location URL: https://www.techscience.com/cmc/v71n3/46465/pdfCitation Count: 3
-
RESTRICTEDTitle: Drug NewsJournal Name: NursingPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 52Issue #: 1Start Page: 8End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nurse.0000803500.30920.0cCitation Count: 0
- Early Autonomic Symptoms Predict Functional Decline in Parkinson’s Disease Independent of Dopaminergic Therapy2022RESTRICTEDTitle: Early Autonomic Symptoms Predict Functional Decline in Parkinson’s Disease Independent of Dopaminergic TherapyJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 22Issue #: 1Start Page: 15End Page: 23Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1159/000525664Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671814Citation Count: 2
- Environmental neurotoxicants and inflammasome activation in Parkinson’s disease – A focus on the gut-brain axis2022RESTRICTEDTitle: Environmental neurotoxicants and inflammasome activation in Parkinson’s disease – A focus on the gut-brain axisJournal Name: The International Journal of Biochemistry & Cell BiologyPublisher: Elsevier BVVol: 142Issue #:Start Page: 106113End Page: 106113Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.biocel.2021.106113Citation Count: 8
- Evaluation of morning bradykinesia in Parkinson’s disease in a United States cohort using continuous objective monitoring2022RESTRICTEDTitle: Evaluation of morning bradykinesia in Parkinson’s disease in a United States cohort using continuous objective monitoringJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 6Issue #:Start Page: 100145End Page: 100145Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100145Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100145Citation Count: 4
-
RESTRICTEDTitle: Evaluation of the Dementia Apraxia Test in Parkinson’s Disease PatientsJournal Name: Dementia and Geriatric Cognitive DisordersPublisher: S. Karger AGVol: 51Issue #: 3Start Page: 271End Page: 278Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1159/000525618Citation Count: 1
-
RESTRICTEDTitle: Extracellular vesicles in pharmacology: Novel approaches in diagnostics and therapyJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 175Issue #:Start Page: 105980End Page: 105980Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.phrs.2021.105980Best OA location URL: http://manuscript.elsevier.com/S1043661821005648/pdf/S1043661821005648.pdfCitation Count: 11
- Extracranial carotid atherosclerosis is associated with increased neurofibrillary tangle accumulation2022RESTRICTEDTitle: Extracranial carotid atherosclerosis is associated with increased neurofibrillary tangle accumulationJournal Name: Journal of Vascular SurgeryPublisher: Elsevier BVVol: 75Issue #: 1Start Page: 223End Page: 228Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jvs.2021.07.238Best OA location URL: http://www.jvascsurg.org/article/S0741521421019819/pdfCitation Count: 2
-
RESTRICTEDTitle: Gastric acid suppressants and cognitive decline in people with or without cognitive impairmentJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12243Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/trc2.12243Citation Count: 4
- GuiltyTargets: Prioritization of Novel Therapeutic Targets With Network Representation Learning2022RESTRICTEDTitle: GuiltyTargets: Prioritization of Novel Therapeutic Targets With Network Representation LearningJournal Name: IEEE/ACM Transactions on Computational Biology and BioinformaticsPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 19Issue #: 1Start Page: 491End Page: 500Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1109/tcbb.2020.3003830Best OA location URL: https://ieeexplore.ieee.org/ielx7/8857/9702518/09121705.pdfCitation Count: 9
-
RESTRICTEDTitle: Hippocampal Functional Connectivity in Parkinson’s DiseaseJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 22Issue #: 1Start Page: 29End Page: 33Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1159/000526377Citation Count: 2
- How Parkinson’s patients in the USA perceive deep brain stimulation in the 21st century: Results of a nationwide survey2022RESTRICTEDTitle: How Parkinson’s patients in the USA perceive deep brain stimulation in the 21st century: Results of a nationwide surveyJournal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 95Issue #:Start Page: 20End Page: 26Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2021.11.017Citation Count: 5
-
RESTRICTEDTitle: Inclusionary Trials: A Review of Lessons Not LearnedJournal Name: Epidemiologic ReviewsPublisher: Oxford University Press (OUP)Vol: 44Issue #: 1Start Page: 78End Page: 86Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/epirev/mxac007Best OA location URL: https://academic.oup.com/epirev/advance-article-pdf/doi/10.1093/epirev/mxac007/45890462/mxac007.pdfCitation Count: 6
- Machine Learning-Based Prediction of Impulse Control Disorders in Parkinson’s Disease From Clinical and Genetic Data2022RESTRICTEDTitle: Machine Learning-Based Prediction of Impulse Control Disorders in Parkinson’s Disease From Clinical and Genetic DataJournal Name: IEEE Open Journal of Engineering in Medicine and BiologyPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 3Issue #:Start Page: 96End Page: 107Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1109/ojemb.2022.3178295Best OA location URL: https://ieeexplore.ieee.org/ielx7/8782705/8937520/09783181.pdfCitation Count: 2
- Mapping of a N-terminal α-helix domain required for human PINK1 stabilization, Serine228 autophosphorylation and activation in cells2022RESTRICTEDTitle: Mapping of a N-terminal α-helix domain required for human PINK1 stabilization, Serine228 autophosphorylation and activation in cellsJournal Name: Open BiologyPublisher: The Royal SocietyVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1098/rsob.210264Best OA location URL: https://doi.org/10.1098/rsob.210264Citation Count: 21
- Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complex2022RESTRICTEDTitle: Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complexJournal Name: Molecular CellPublisher: Elsevier BVVol: 82Issue #: 1Start Page: 44End Page: 59.e6Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.molcel.2021.11.012Best OA location URL: http://www.cell.com/article/S1097276521009916/pdfCitation Count: 46
- Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer’s disease topography2022RESTRICTEDTitle: Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer’s disease topographyJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 35Issue #:Start Page: 103080End Page: 103080Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103080Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103080Citation Count: 13
- Mobility endpoints in marketing authorisation of drugs: what gets the European medicines agency moving?2022RESTRICTEDTitle: Mobility endpoints in marketing authorisation of drugs: what gets the European medicines agency moving?Journal Name: Age and AgeingPublisher: Oxford University Press (OUP)Vol: 51Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1093/ageing/afab242Best OA location URL: https://academic.oup.com/ageing/article-pdf/51/1/afab242/42261496/afab242.pdfCitation Count: 7
-
RESTRICTEDTitle: Movement disorders research in 2021: cracking the paradigmJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 1Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00413-0Citation Count: 15
- NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson’s disease using convolutional neural network2022RESTRICTEDTitle: NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson’s disease using convolutional neural networkJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 36Issue #:Start Page: 103250End Page: 103250Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103250Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103250Citation Count: 5
- Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core study2022RESTRICTEDTitle: Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core studyJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12329Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398229Citation Count: 12
-
RESTRICTEDTitle: Poster SessionJournal Name: Rinsho ShinkeigakuPublisher: Societas Neurologica JaponicaVol: 62Issue #: SupplementStart Page: S247End Page: S393Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.5692/clinicalneurol.62_supplement_s247Best OA location URL: https://www.jstage.jst.go.jp/article/clinicalneurol/62/Supplement/62_62_supplement_S247/_pdfCitation Count: 0
- POSTERS - 15th Conference Clinical Trials Alzheimer’s Disease, November 29- December 2, 2022, San Francisco, CA, USA2022RESTRICTEDTitle: POSTERS - 15th Conference Clinical Trials Alzheimer’s Disease, November 29- December 2, 2022, San Francisco, CA, USAJournal Name: The Journal of Prevention of Alzheimer's DiseasePublisher: SERDIVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.14283/jpad.2022.97Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734609Citation Count: 2
- Profiles of women in science: Malú Gámez Tansey, Norman and Susan Fixel Professor of Neuroscience and Neurology, Co‐Director of the Center for Translational Research in Neurodegenerative Disease and Director of the Parkinson's Foundation Research Center of Excellence, University of Florida College of Medicine2022RESTRICTEDTitle: Profiles of women in science: Malú Gámez Tansey, Norman and Susan Fixel Professor of Neuroscience and Neurology, Co‐Director of the Center for Translational Research in Neurodegenerative Disease and Director of the Parkinson's Foundation Research Center of Excellence, University of Florida College of MedicineJournal Name: European Journal of NeurosciencePublisher: WileyVol: 55Issue #: 2Start Page: 350End Page: 353Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.15578Citation Count: 0
-
RESTRICTEDTitle: Profiling Parkinson’s disease cognitive phenotypes via resting-state magnetoencephalographyJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 127Issue #: 1Start Page: 279End Page: 289Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1152/jn.00316.2021Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782645Citation Count: 8
- Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study2022RESTRICTEDTitle: Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 1Start Page: 53End Page: 65Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00368-9Citation Count: 39
-
RESTRICTEDTitle: Should “on-demand” treatments for Parkinson’s disease OFF episodes be used earlier?Journal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 7Issue #:Start Page: 100161End Page: 100161Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100161Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100161Citation Count: 7
-
RESTRICTEDTitle: Sorting (Nexin-13) out Novel Insights into Endolysosomal Cholesterol ExportJournal Name: ContactPublisher: SAGE PublicationsVol: 5Issue #:Start Page: 251525642211145End Page: 251525642211145Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/25152564221114513Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/25152564221114513Citation Count: 1
-
RESTRICTEDTitle: Subcellular and regional localization of mRNA translation in midbrain dopamine neuronsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 110208End Page: 110208Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2021.110208Best OA location URL: http://www.cell.com/article/S2211124721017125/pdfCitation Count: 25
-
RESTRICTEDTitle: The neuropsychiatry of Parkinson's disease: advances and challengesJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 1Start Page: 89End Page: 102Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00330-6Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800169Citation Count: 151
-
RESTRICTEDTitle: Therapeutics in the Pipeline Targetingα-Synuclein for Parkinson's DiseaseJournal Name: Pharmacological ReviewsPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 74Issue #: 1Start Page: 207End Page: 237Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1124/pharmrev.120.000133Best OA location URL: https://pharmrev.aspetjournals.org/content/pharmrev/74/1/207.full.pdfCitation Count: 39
- Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders2022RESTRICTEDTitle: Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disordersJournal Name: Pharmacology & TherapeuticsPublisher: Elsevier BVVol: 229Issue #:Start Page: 107937End Page: 107937Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pharmthera.2021.107937Citation Count: 34
- Validation of an automatic tool for the rapid measurement of brain atrophy and white matter hyperintensity: QyScore®2022RESTRICTEDTitle: Validation of an automatic tool for the rapid measurement of brain atrophy and white matter hyperintensity: QyScore®Journal Name: European RadiologyPublisher: Springer Science and Business Media LLCVol: 32Issue #: 5Start Page: 2949End Page: 2961Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00330-021-08385-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00330-021-08385-9.pdfCitation Count: 10